-
Five HIV patients left ‘virus-free’ with no need for daily drugs in early vaccine trials
A new vaccine-based treatment for HIV has succeeded in suppressing the virus in five patients, raising hopes further research could help prevent Aids without the need for daily drugs. Researchers combined two innovative HIV vaccines with a drug usually used to treat cancer in the trial, conducted over three years at the IrsiCaixa Aids Research Institute in Barcelona.
- Categories
- Health Care
- Region
- Europe & Eurasia
- Tags
- public health, research
-
Enthusiasm for SRI Is Driving Changes In Wealth Management Units
At The Economist’s Impact Investing conference last week, Andy Sieg, the new leader of Bank of America’s Merrill Lynch Wealth Management said the “herd”—a moniker for the firm's network of more than 15,000 advisors—has never been as interested in socially responsible investing as it is now.
- Categories
- Impact Assessment, Investing
-
Still Helping Nonprofits Finance Solar Power Systems, But With A Simpler Funding Model
When readers last encountered CollectiveSun three years ago, the San Diego-based social enterprise had recently launched. Its mission: to help small nonprofits finance solar projects. Since that time, the goal hasn’t changed, but the financing model has.
- Categories
- Energy, Impact Assessment
- Tags
- solar
-
Woman-Led Tala Raises $30 Million Series B For Micro-Loans Via Smartphone
Tala, a startup that makes micro-loans to entrepreneurs in the developing world via smartphone app, has raised a $30 million Series B round as it expands into new geographical markets.
- Categories
- Investing, Technology
- Tags
- fintech, venture capital
-
Kenya: Safaricom Faces M-Pesa Break Up in Market Dominance War
Telecoms operator Safaricom could be forced to hive off its popular mobile money service M-Pesa if sector regulator, the CA, moves to implement recommendations of a market dominance report.
- Categories
- Technology
- Region
- Sub-Saharan Africa
-
A Highly Preventable Disease With a Vaccine Is Silently Killing Indian Women in Their Prime
A cancer with an effective vaccine is killing thousands of women. Last year, nearly 70,000 Indians died of cervical cancer, more than anywhere else in the world. It’s the second-most common cancer among women in the country, accounting for 23% of all cases. It’s a hidden disease, often taking 20 years to show itself.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Education Experts Square Off on the Public Versus Private School Debate in Africa
Although it may seem counterintuitive, nearly three times as many primary school children are enrolled in private schools in developing countries than in developed ones, according to United Nations figures.
- Categories
- Education
- Region
- Sub-Saharan Africa
-
Why Omidyar Network is Excited About Technology Stacks for Financial Inclusion
There are a lot of buzzwords out there when it comes to technology, so we try not to get caught up with each new fad. But everywhere we look, we see a concept that promises to be a powerful driver of not only innovation, but also economic progress: technology stacks.
- Categories
- Technology
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.